Amyloid Forming Human Lysozyme Intermediates are Stabilized by Non‐Native Amide‐π Interactions
Advanced Science · 2025
DOI: 10.1002/advs.202503957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Minkoo Ahn und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biochemistry, University of Bristol, University Walk, Bristol, BS8 1TD, UK. Hauptthemen laut MEDLINE: Muramidase, Amyloid, Amides. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia (FCT), Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Mutational variants of human lysozyme cause a rare but fatal hereditary systemic amyloidosis by populating an intermediate state that self‐assembles into amyloid fibrils. However, this intermediate state is recalcitrant to detailed structural investigation, as it is only transiently and sparsely populated. Here, this work investigates the intermediate state of an amyloid‐forming human lysozyme variant (I59T) using CEST and CPMG RD NMR at low pH. 15 N CEST profiles probe the thermal unfolding of the native state into the denatured ensemble and reveal a distinct intermediate state. Global fitting of 15 N CEST and CPMG data provides kinetic and thermodynamic parameters, characterizing the intermediate state populated at 0.6%. 1 H CEST data further confirm the presence of the intermediate state displaying unusually high or low 1 H N chemical shifts. To investigate the structural details of this intermediate state, this work uses molecular dynamics (MD) simulations, which recapitulate the experimentally observed folding pathway and free energy landscape. This work observes a high‐energy intermediate state with a locally disordered β‐domain and C‐helix, stabilized by non‐native hydrogen bonding and amide‐π interactions, accounting for its anomalous 1 H chemical shifts. Together, these NMR and MD data provide the first direct structural information on the intermediate state, offering insights into targeting lysozyme amyloidosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biochemistry, University of Bristol, University Walk, Bristol, BS8 1TD, UK.
- Research Department of Structural and Molecular Biology, Biosciences, University College London, Gower Street, London, WC1E 6BT, UK.
- Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
- Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, UK.
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, Warsaw, 02-106, Poland.
- Coimbra Chemistry Centre, Institute of Molecular Sciences (CQC-IMS), Department of Chemistry, Faculty of Science and Technology, University of Coimbra, Coimbra, 3004-531, Portugal.
ORCID-Profile: Minkoo Ahn, Julian O Streit, Christopher A Waudby, Tomasz Włodarski, Angelo Miguel Figueiredo, John Christodoulou, Janet R Kumita
Förderung
- Fundação para a Ciência e a Tecnologia (FCT)
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Ahn, M., Streit, J. O., Waudby, C. A., Włodarski, T., Figueiredo, A. M., Christodoulou, J., & Kumita, J. R. (2025). Amyloid Forming Human Lysozyme Intermediates are Stabilized by Non‐Native Amide‐π Interactions. Advanced Science. https://doi.org/10.1002/advs.202503957
Vancouver
Ahn M, Streit JO, Waudby CA, Włodarski T, Figueiredo AM, Christodoulou J, et al. Amyloid Forming Human Lysozyme Intermediates are Stabilized by Non‐Native Amide‐π Interactions. Advanced Science. 2025. doi:10.1002/advs.202503957
BibTeX
@article{Ahn2025,
author = {Ahn, Minkoo and Streit, Julian O and Waudby, Christopher A and Włodarski, Tomasz and Figueiredo, Angelo Miguel and Christodoulou, John and Kumita, Janet R},
title = {Amyloid Forming Human Lysozyme Intermediates are Stabilized by Non‐Native Amide‐π Interactions},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202503957}
}
EUVIMED